October 14 (Hfrance.fr) - A panel of expert advisers from the US Food and Drug Administration voted unanimously on Thursday to recommend booster injections from Moderna Inc. (MRNA.O) COVID-19 vaccine for Americans 65 and over elderly and those at high risk of serious illness.
If the FDA approves Moderna's recall, the US Centers for Disease Control and Prevention will specific recommendations on who should get the vaccine. CDC advisers are scheduled to meet next week.
The Vaccines and Biologics Advisory Committee related FDA met on Thursday to review the additional dose of Moderna vaccine and evawill read whether to make a similar recommendation for (JNJ.N) vaccine Friday. The vote to support Moderna's recall was 19-0.
Moderna is requesting authorization of a recall that contains 50 micrograms of vaccine, half the strength of its regular dose but still higher than the Pfizer / BioNTech shot at 30 micrograms.
In addition to those 65 and over and those at risk of severe COVID-19, the expert panel voted to recommend the authorization of a third cycle of the Moderna vaccine for people aged 18 to 64 at risk of frequent exposure to infections with coronavirus because of their work. The injections would be given to people at least six months after the initial inoculation as two injections.
the people in chargeHealth officials have been under pressure to allow booster doses of the COVID-19 vaccine after the White House announced in August that it was planning a large-scale recall campaign pending FDA and CDC approvals .
The two agencies signed on Pfizer / BioNTech Boosters for some high risk adults last month. Since then, nearly 9 million people have received a third injection, the CDC reported on Wednesday. Reporting by Manas Mishra in Bengaluru, Julie Steenhuysen in Chicago, Michael Erman in New Jersey and Caroline Humer in New Jersey York; Edited by Lisa Shumaker and Bill Berkrot
Our standards: Thomson Hfrance.fr's principles of trust.